Spelling suggestions: "subject:"neuropathy."" "subject:"neuropathyc.""
241 |
Vyšetření vegetativního systému u dědičné neuropatie / Examination of vegetative system in hereditary neuropathyJílková, Daniela January 2011 (has links)
Aim: The aim of this thesis "Examination of vegetative system in hereditary neuropathy" is to consider the level of physical fitness, physical actvity level and quality of autonomic function in patients with hereditary neuropathy Charcot Marie Tooth and an assessment of interactions of these parameters, especially with regard to possible influence by the presence of autonomic neuropathy and with regard to neurological symptoms. Background: Although vegetative neuropathy was mentioned in the first publication about CMT, it is not widely discussed topic as part of it. Methods: Seventeen probands underwent spiroergometry, heart rate variability test, six minute walk test, rating by the CMT Neuropathy Score and Overall neuropathy disability scale and completing the IPAQ questionnaire. Results: We found symptoms of autonomic neuropathy in group of patients with CMT, especially high-frequency part of heart rate variability spectrum has a particularly significant decrease. Patients with autonomic neuropathy have shown a low fitness and functional capacity, tendency to obesity and hypertension. The observed correlation of autonomic neuropathy and neurological impairment was very weak. Conclusions: We find a neuropathy of the autonomic nervous system in patiens with hereditary motor and sensitive neuropathy...
|
242 |
Wirksamkeit medikamentöser und myofunktioneller Therapiekonzepte beim chronischen Gesichtsschmerz / Efficacy of drug and myofunctional therapy concepts in chronic facial painSchöne, Patrick 06 July 2016 (has links)
No description available.
|
243 |
Modulation of TRPV1 function in sensory neuropathyPritchard, Sara January 2015 (has links)
This thesis examined how and why TRPV1 function is being modulated in sensory neuropathy and explored the potential of its rescue in the urinary bladder of STZ-‐induced diabetic rats. Diabetes induced a rapid decline in TRPV1 function and changes in neurogenically mediated electrically-‐evoked responses together with a gradual decline in muscarinic function. Diabetic bladder was also deficient in muscarinic and TRPV1 organ bath temperature-‐induced changes but not in those affecting spontaneous contractile activity. Exposure to a potential neuropathy causative agent, methylglyoxal was studied and its mechanism of action explored through the use of TRPA1 ligands. Methylglyoxal exposure mimicked some of the effects of diabetes on TRPV1, neurogenic electrically evoked responses and muscarinic function. Methylglyoxal effects were seen to be partly through TRPA1 receptor activation but other as yet undefined pathways were also involved. Use of TRPA1 ligands revealed an unexpected complexity of the interaction of the TRPA1 receptor with TRPV1. Finally the potential of reversing the diminished TRPV1 response was examined through the use of three known sensitising agents, bradykinin, NGF and insulin. Bradykinin was the only agent seen to reverse the TRPV1 diminished response back up to to control equivalent levels and through the use of bradykinin selective ligands, it was seen that the dual activation of BK-‐1 and BK-‐2 receptor was necessary to rescue the TRPV1 response. The likely mechanism of action of bradykinin was through prostaglandin production as indomethacin blocked TRPV1 rescue. In the acute stage of diabetes, TRPV1 function is downregulated and may be caused by exposure to a neuropathy-‐causing metabolite such as methylglyoxal. The TRPV1 function still retains plasticity at this acute stage because function could be enhanced back to control levels by bradykinin receptor activation : a potential for early therapeutic intervention.
|
244 |
Pathogenèse moléculaire de la neuropathie sensitive et motrice héréditaire avec agénésie du corps calleuxSalin, Adèle 09 1900 (has links)
La neuropathie sensitive et motrice héréditaire avec agénésie du corps calleux (NSMH/ACC) se traduit par une atteinte neurodégénérative sévère associée à des anomalies développementales dans le système nerveux central et du retard mental. Bien que rare dans le monde, ce désordre autosomique récessif est particulièrement fréquent dans la population Québécoise du Canada Français du fait d’un effet fondateur. L’unique étude réalisée sur la mutation québécoise du gène qui code pour le co-transporteur de potassiumchlore 3 (KCC3) a montré qu’il y a une perte de fonction de la protéine. Cependant, la maladie est également retrouvée hors du Québec et il reste encore à élucider les pathomécanismes mis en jeu.
Nous avons donc séquencé les 26 exons du gène KCC3 chez des individus recrutés dans le monde entier et suspectés d’être atteints de la maladie. Nous avons ainsi identifié trois nouvelles mutations. L’étude fonctionnelle de ces mutations nous a confirmé la perte de fonction systématique des co-transporteurs mutés. Puisque l’inactivation de KCC3 se produit majoritairement via l’élimination de segments peptidiques en C-terminus, nous avons concentré notre attention sur l’identification des interactions qui s’y produisent. À l’aide d’approches double hybride, pull-down et immunomarquage, nous avons déterminé que KCC3 interagit avec la créatine kinase CK-B et que cette interaction est perturbée par les mutations tronquantes. De plus, l’utilisation d’un inhibiteur de créatine kinase inactive KCC3, ce qui démontre qu’il existe bien un lien fonctionnel et pathologique entre KCC3 et ses partenaires C-terminaux. Nous avons aussi identifié des anomalies majeures de localisation membranaire des KCC3 mutés. Que KCC3 soit tronqué ou pleine longueur, sa distribution subcellulaire est affectée dans des cellules en culture, dans les ovocytes de Xenopes et dans des échantillons de cerveau de patients. La perte d’interaction entre KCC3 et CK-B et/ou les défauts de transit intracellulaire de KCC3 sont donc les mécanismes pathologiques majeurs de la NSMH/ACC. / Heredirary motor and sensory neuropathy with agenesis of the corpus callosum (HMSN/ACC) is a severe neurodegenerative disease associated with developmental anomalies in the central nervous system and mental retardation. Although rare worldwide, this autosomal-recessive disorder is frequent in the French-Canadian population of Quebec because of a founder effect. Different mutations in the gene coding for the potassiumchloride co-transporter 3 (KCC3) have been associated with the disease; however, little is known about the mechanisms leading to the inactivation of the co-transporter.
We sequenced 26 exons of the KCC3 gene in individuals recruited worldwide and suspected to be affected by the disease. We identified three new mutations. The functional study of these mutations gave confirmation of a systematic loss-of-function of the mutant co-transporters. As the loss of function occurs mainly via the elimination of C-terminal peptide fragments, we focused on the identification of C-terminal interacting partners. Using different biochemical approaches, such as yeast two-hydbrid, pull-down, and immunostaining, we established that KCC3 interacts with the brain-type creatine kinase CK-B and that this interaction is disrupted by the HMSN/ACC truncation mutations. In addition, a specific creatine kinase inhibitor inactivates KCC3 and shows for the first time the functional link between KCC3 and its C-terminal partners. In addition, we found that anomalies in KCC3 transit—as seen in cultured cells, in Xenopus oocytes, and in human brain samples—is a major pathogenic mechanism that also leads to the disease manifestations.
|
245 |
Cyanocobalamin is a Superoxide Scavenger and Neuroprotectant in Neuronal CellsChan, Wesley 04 1900 (has links)
Les dommages au nerf optique (neuropathie optique) peuvent entraîner la perte permanente de la vision ou la cécité causée par la mort des cellules ganglionnaires de la rétine (CGR). Nous avons identifié qu’une surproduction de l'anion superoxyde constitue un événement moléculaire critique précédant la mort cellulaire induite par des lésions. Récemment, Suarez-Moreira et al (JACS 131:15078, 2009) ont démontré que la vitamine B12 peut capter l’anion superoxyde aussi efficacement que l’enzyme superoxyde dismutase. La carence en vitamine B12 peut conduire à une neuropathie optique causée par des mécanismes inconnus. Nous avons étudié la relation entre la captation de superoxyde par la cyanocobalamine (forme de vitamine B12 la plus abondante) et ses propriétés neuroprotectrices dans les cellules neuronales.
La cyanocobalamine aux concentrations de 10 μM et 100 μM a réduit le taux de production de superoxyde respectivement par 34% et 79% dans les essais sans-cellule. Dans les cellules RGC-5 traités avec la ménadione, les concentrations de cyanocobalamine supérieures à 10 nM ont diminué l’anion superoxyde à des valeurs similaires à celles traitées par PEG-SOD. La cyanocobalamine aux concentrations de 100 μM et 1 μM a réduit la mort des cellules RGC-5 exposées à la ménadione par 20% et 32%, respectivement. Chez les rats avec section du nerf optique unilatérale, une dose intravitréenne de 667 μM de cyanocobalamine a réduit le nombre de CGRs exposées au superoxyde. Cette dose a également augmenté le taux de survie des CGRs comparativement aux rats injectés avec la solution témoin. Ces données suggèrent que la vitamine B12 peut être un neuroprotecteur important, et sa carence nutritionnelle pourrait causer la mort de CGRs. La vitamine B12 pourrait aussi potentiellement être utilisée comme une thérapie pour ralentir la progression de la mort CGR chez les patients avec les neuropathies optiques caractérisés par une surproduction de superoxyde. / Damage to the optic nerve (optic neuropathy) can result in permanent loss of vision or blindness through retinal ganglion cell (RGC) death. Our prior work identified a burst of superoxide anion as a critical molecular event in RGCs prior to injury-induced cell death. Recently, Suarez-Moreira et al (JACS 131:15078, 2009) demonstrated that vitamin B12 scavenges superoxide as effectively as superoxide dismutase. Vitamin B12 deficiency can lead to optic neuropathy through unknown mechanisms. We investigated the relationship between superoxide scavenging by cyanocobalamin, the most abundant vitamin B12¬¬ vitamer, and its neuroprotective properties in neuronal cells.
Cyanocobalamin at concentrations of 10 μM and 100 μM reduced the rate of superoxide generation by 34% and 79% in cell free assays, respectively. In menadione-treated RGC-5 cells, cyanocobalamin concentrations above 10 nM scavenged superoxide anion similar to those treated with pegylated-SOD. Cyanocobalamin at concentrations of 100 μM and 1 mM reduced RGC-5 cell death from menadione by 20% and 32%, respectively. In rats with unilateral optic nerve transection, a single intravitreal dose of 667 μM cyanocobalamin significantly reduced the number of RGCs with superoxide. This dose also increased RGC survival rate compared to rats injected with saline control.
These data suggest that vitamin B¬¬12 may be an important neuroprotectant, which could cause death of RGCs when depleted in nutritional deficiency. Vitamin B12 could also potentially be used as a therapy to slow progression of RGC death in patients with optic neuropathies characterized by overproduction of superoxide.
|
246 |
Role de desert hedgehog dans l’angiogenese post-ischemique et le maintien de l’integrite du reseau vasculaire endoneural chez l’adulte / Role of desert hedgehog in post-ischemic angiogenesis and in maintaining endoneurial vascular network in adultChapouly, Candice 28 October 2013 (has links)
Le diabète est une maladie grave et très fréquente. Elle est responsable de complications macrovasculaires dont l’artérite des membres inférieurs et microvasculaires dont les neuropathies périphériques. Desert hedgehog (Dhh) est l’un des trois membres de la famille hedgehog (Hh); cette protéine est notamment exprimée par les nerfs périphériques dont elle permet l’organisation structurale. Les membres de la famille Hh sont en outre impliqués dans la régulation de la physiologie des vaisseaux sanguins. Du fait de la diminution de l’expression de Dhh dans des conditions pathologiques comme le diabète, l’objectif de cette thèse a été de comprendre le rôle de cette protéine dans la physiopathologie des complications vasculaires associées au diabète. Nous avons montré d’une part que le défaut de Dhh altère la survie des nerfs en condition ischémique et ainsi entraîne un défaut de production par le nerf des facteurs pro-angiogéniques nécessaire à la réparation musculaire. D’autre part nous avons mis en évidence que le défaut d’expression de Dhh dans le nerf diabétique est responsable de la perte de l’intégrité de la barrière nerf-vaisseau et en conséquence de la neuropathie diabétique. Dhh apparait donc comme un nouvel acteur important du cross-talk nerf-vaisseau. La compréhension de sa fonction et de sa signalisation en font un candidat intéressant pour le développement de nouvelles stratégies thérapeutiques (thérapie génique Dhh, agonistes de la voie Hh) dans le traitement des complications du diabète. / Diabetes is a serious and frequent illness. It is responsible for macrovascular complications such as peripheral arterial disease and microvascular complications such as peripheral neuropathy. Desert Hedgehog (Dhh) is one of the three hedgehog (Hh) family members; this protein is expressed by Schwann cells of peripheral nerves and is necessary to orchestrate the organisation of nerve sheaths (i.e. Epi-, Peri-, and Endoneurium) by signaling to perineurial cells. Moreover, the Hh family members are also known to regulate blood vessel physiology. Because we found that Dhh is downregulated in pathological conditions such as diabetes, the purpose of this PhD thesis is to understand the contribution of Dhh in diabetes-associated vascular complications. We have shown that Dhh deficiency impairs peripheral nerve survival in the ischemic muscle and, by doing so, decreases the pool of nerve-derived proangiogenic factors. Then we have found that Dhh knockdown in peripheral nerves is responsible for blood nerve barrier breakdown and consequently diabetic neuropathy. Dhh appears as a new actor that plays a crucial role in nerve-vessel cross-talk. The understanding of Dhh function and signaling makes it an interesting candidate for the development of new therapeutic strategies (gene therapy, Hh agonists) in the setting of diabetic complications.
|
247 |
Změny termického prahu u pacientů léčených pro hypothyreózu / Changes of thermal thresholds in patients treated with hypothyroidism.Zůna, Miroslav January 2013 (has links)
Diplomová práce Miroslav Zůna 3 Author's first name and surname: Miroslav Zůna, BA. Title of the master thesis: Changes of thermal thresholds in patients treated with hypothyroidism. Department: Department of Physiotherapy and Sports Medicine Supervisor: Hana Marčišová, MA. The year of presentation: 2013 Abstract: Disorders of thyroid gland together with diabetes are most common endocrine diseases in Czech Republic and worldwide, too. Myopathy and neuropathy, caused by reduced amount of thyroid hormones, are mentioned in current literature, however pathaphysiological mechanisms stay unclear. To evaluate the state of small nerve fibers that should be affected first, we use thermal threshold testing, setting the thermal threshold for warm and cold stimuli in different locations. Patients with hypothyroidism show in most of the measured locations higher thermal threshold than that of the control group, however these results are not significant. Significant change of thermal sensation of cold stimulus is demonstrated in location thenar. Patients with hypothyroidism also have a higher degree of inaccuracy detection of thermal stimuli. A greater number of significant conclusions can not seem to reach for a small number of probands participating in our study or due to ongoing therapy and the resulting normal state...
|
248 |
Hypermobility syndrome and its connection with nerve entrapment syndromes, the example of the thoracic outlet syndromeJiquelle, Carine January 2013 (has links)
ABSTRACT Background: Since its first mention by Kirk et al. in 1967 and its recognition as a full- fledged rheumatologic disorder, the hypermobility syndrome (HMS) has been increasingly investigated and reported in the scientific literature. Expeditiously renamed benign joint hypermobility syndrome in the patent absence of life-threatening complications, its relatively innocuous character has been progressively reconsidered. In fact, the HMS tends to date to be considered analogous to the Ehlers-Danlos syndrome-hypermobility type, a heritable disease of connective tissue, and therefore emerges as a chiefly rheumatologic disorder with possible widespread reverberations in practically all organs and systems. The condition thence goes beyond the sole involvement of the musculoskeletal system and is recurrently associated with seemingly-unrelated and more or less severe conditions (cardiovascular, pulmonary, gastro- intestinal…). However, neurologic implications of the hypermobility syndrome remain poorly documented, particularly those regarding the peripheral nervous system. Ranking amongst the afflictions of the latter, nerve entrapment syndromes (NES) comprehend a multitude of categories, notably the thoracic outlet syndrome (TOS). And if their pathological mechanisms are generally apprehended...
|
249 |
Troubles visuels chroniques, nystagmus pendulaire et oscillopsie dans la sclérose en plaques / Chronic visual dysfunctions, pendular nystagmus and oscillopsia in multiple sclerosisJasse, Laurence 05 May 2011 (has links)
Les manifestations neuro-ophtalmologiques, observées dans la sclérose en plaques sont parfaitement déterminées à l’heure actuelle. Cependant, l’aspect chronique des troubles visuels résultants n’est pas toujours précisément évalué, or de telles lacunes sont un frein à leur prise en charge. Dans une première partie, les caractéristiques des troubles visuels chroniques ont été mesurées. Il s’agissait de quantifier le pourcentage de plaintes visuelles chroniques chez des patients atteints de sclérose en plaques puis de mesurer le degré d’intensité des troubles visuels chroniques, de déterminer leurs origines physiopathologiques et de rendre compte de leur retentissement sur la qualité de vie des patients se plaignant de troubles chroniques. Les voies visuelles afférentes étaient altérées dans 68% des cas. Des troubles oculomoteurs étaient fréquemment observés (89%) dont le nystagmus pendulaire (28%), source de gêne visuelle. Dans une seconde partie, nous nous sommes donc intéressés au nystagmus pendulaire et à sa conséquence fonctionnelle, l’oscillopsie, afin de proposer une prise en charge spécifique. Néanmoins, les mécanismes de ce nystagmus ne sont pas encore bien définis. Il était donc important de développer une hypothèse explicative à partir de l’observation de deux cas particuliers de nystagmus monoculaire et de démontrer que le nystagmus pendulaire de la sclérose en plaques est à distinguer du nystagmus pendulaire du tremblement oculopalatin, souvent confondus. Enfin, nous proposons une méthode évaluant la détection du mouvement (par stimuli de contraste asservis au regard) ainsi qu’un protocole de stimulation optocinétique tentant de réduire ce symptôme / Neuro-ophthalmic manifestations observed in multiple sclerosis are well-known. However, the chronic feature of visual dysfunctions is not always precisely determinated. These imprecision impede the development of specific therapeutic approach. In a first part, the chronic characteristics of visual dysfunctions were assessed. The percentage of chronic visual complaints in multiple sclerosis patients was quantified and then the intensity of chronic visual deficits was measured, their pathophysiologic origins determined and finally their impact on quality of life was taken into account. Visual pathways were impaired in 68% of patients. Ocular motor disorders were frequently observed (89%) including pendular nystagmus (28%), accounted for visual discomfort. In a second part, we focused on pendular nystagmus and its functional consequence, oscillopsia, to propose a specific treatment. First of all, the mechanisms of this nystagmus are not yet well defined. Therefore, we developed some hypothesis from the observation of two patients with monocular nystagmus and demonstrated in a second part that the pendular nystagmus in multiple sclerosis is distinct from the pendular nystagmus of oculopalatal tremor. Finally, we proposed a method evaluating oscillopsia (motion detection by contrast stimuli moving synchronically with gaze) that was tested before and after an optokinetic stimulation protocol aimed to reduce this symptom
|
250 |
Manifestações linguísticas em adultos com alterações no espectro da neuropatia auditiva / Linguistic manifestations in adults individuals with auditory neuropathy spectrum disorderHoracio, Camila Paes 07 July 2010 (has links)
Introdução: A presença de perdas auditivas de origem neural no adulto que já desenvolveu linguagem pode acarretar alteração de compreensão da fala com dificuldade na discriminação auditiva dos sons e entendimento completo da mensagem. Entre as causas de perdas auditivas neurais está o distúrbio do espectro da neuropatia auditiva (DENA). A maioria das publicações sobre o DENA descrevem o padrão do diagnóstico auditivo, entretanto as consequências dessa alteração auditiva para a comunicação do indivíduo e as implicações dessas para o tratamento fonoaudiólogico são escassas. Faz-se necessária a identificação das especificidades linguísticas a serem avaliadas nos neuropatas, por meio de um protocolo de avaliação direcionado, para permitir a elaboração de diretrizes terapêuticas bem delineadas. Objetivo: Este estudo teve como objetivo descrever as manifestações linguísticas em adultos com o Distúrbio do espectro da neuropatia auditiva (DENA). Métodos: Foram incluídos neste estudo pacientes adultos identificados com o diagnóstico de DENA, alfabetizados, sem alterações neurológicas e cognitivas, no período entre 2007 e 2009 no setor de Fonoaudiologia do Ambulatório de Otorrinolaringologia do HCFMUSP. Doze pacientes foram selecionados, sendo 8 do sexo masculino (66,7%), com idades entre 18 e 50 anos. Foi elaborado um protocolo de anamnese incluindo dados sobre escolaridade, uso de amplificação sonora individual (AASI) e queixas auditivas específicas. O protocolo de avaliação constou de provas que abordaram a avaliação da recepção auditiva e da emissão de fala (identificação fonêmica; inteligibilidade; leitura e compreensão de texto e consciência fonológica) e da expressão (fala e elaboração). Os estímulos foram dados por via somente auditiva e no modo auditivo e visual (com leitura orofacial - LOF). Resultados: As principais características observadas nestes pacientes: sexo masculino, ensino fundamental incompleto, uso de AASI menor que três meses em ambas as orelhas, dificuldade de ouvir em ambientes ruidosos e diálogo foram as situações comunicativas que geraram maior dificuldade na expressão. Observou-se que em todas as provas com apoio da LOF, houve melhora significativa da percepção da fala do ponto de vista clínico. Conclusões: As especificidades linguísticas dos pacientes adultos com DENA encontradas foram: baixa escolaridade, velocidade de fala alterada, dificuldade de compreensão de texto tanto pela via auditiva como pela leitura, dificuldade de consciência fonológica, melhora da repetição de palavras e frases com o uso da LOF. / Introduction: Post linguistic neural hearing loss in adults can lead to speech alterations and difficulties in auditory discrimination of sounds and comprehension of the message. Auditory neuropathy spectrum disorder (ANSD) is among the causes of neural hearing loss. Most studies on ANSD describe the standard for auditory diagnosis. However, the consequences of such hearing impairment in communication and its implication on speech therapy are scarce. Thus, it is necessary to identify the specific language aspects to be assessed in neurologically impaired individuals through a directed assessment protocol to allow the development of outlined treatment guidelines. Objective: This study aimed to describe the linguistic manifestations in adults with ANSD. Methods: The study included adults diagnosed with ANSD, who were literate and had no neurological or cognitive alterations. Data collection was carried out between 2007 and 2009 at the Speech, Language and Hearing service of the Clinic of Otorhinolaryngology of HCFMUSP. Twelve patients, eight males (66,7%) with ages ranging from 18 and 50 years of age were selected. An anamnesis protocol was designed. This protocol included data on education, use of hearing aids (HA) and specific hearing complaints. The assessment protocol consisted on tests of auditory reception and production of speech (phonemic identification; intelligibility; reading and text comprehension; and phonological awareness) and expression (speech and elaboration). The stimuli input were given in auditory only and in auditory plus visual mode (with lip reading). Results: The main characteristics observed in all participants were: male gender; incomplete primary school; use of hearing aids for less than three months in both ears; difficulty hearing in noisy environments; and dialogue, were the communicative situations that led to greater difficulty in expression. A significant improvement in speech perception was observed in all tests with lip reading. Conclusions: The language specificities of individuals with ANSD were: low educational level; speech rate alterations; difficulty in reading comprehension both by hearing and by reading; difficulty in phonological awareness; improvement of words and phrases repetition using LR.
|
Page generated in 0.0504 seconds